FDA Grants Breakthrough Device Designation For Seastar Medical'S Selective Cytopheretic Device For Adults Undergoing Chronic Dialysis

  • Kevin Chung

Press/Media

Period6 Nov 2024

Media coverage

1

Media coverage

  • TitleFDA Grants Breakthrough Device Designation For Seastar Medical'S Selective Cytopheretic Device For Adults Undergoing Chronic Dialysis
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date6/11/24
    PersonsKevin Chung
View all 1
View less